{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T08:12:48Z","timestamp":1742803968214,"version":"3.40.2"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-04142-2","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T17:06:56Z","timestamp":1735060016000},"page":"304-314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary hyperparathyroidism in patients with thyroid cancer: prevalence and prognosis in a retrospective monocentric study"],"prefix":"10.1007","volume":"88","author":[{"given":"I.","family":"Patelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Comina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Musso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"De\u2019Luca Di Pietralata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Minuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Albertelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bagnasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ferone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"issue":"1","key":"4142_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"B.R. Haugen, E.K. Alexander, K.C. Bible et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1\u2013133 (2016). https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"key":"4142_CR2","unstructured":"AIOM. Linee guida AIOM tumori della tiroide. Aiom. Published online 2021."},{"issue":"8","key":"4142_CR3","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1055\/a-1089-7870","volume":"52","author":"KA Araque","year":"2020","unstructured":"K.A. Araque, S. Gubbi, J. Klubo-Gwiezdzinska, Updates on the management of thyroid cancer. Horm. Metab. Res. 52(8), 562\u2013577 (2020). https:\/\/doi.org\/10.1055\/a-1089-7870","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"4142_CR4","doi-asserted-by":"publisher","first-page":"e220293","DOI":"10.1530\/ERC-22-0293","volume":"30","author":"C Christofer Juhlin","year":"2023","unstructured":"C. Christofer Juhlin, O. Mete, Z.W. Baloch, The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading. Endocr. Relat. Cancer 30(2), e220293 (2023). https:\/\/doi.org\/10.1530\/ERC-22-0293","journal-title":"Endocr. Relat. Cancer"},{"issue":"12","key":"4142_CR5","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","volume":"30","author":"S Filetti","year":"2019","unstructured":"S. Filetti, C. Durante, D. Hartl et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 30(12), 1856\u20131883 (2019). https:\/\/doi.org\/10.1093\/annonc\/mdz400","journal-title":"Ann. Oncol."},{"issue":"5","key":"4142_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"L. Boucai, M. Zafereo, M.E. Cabanillas, Thyroid cancer: a review. JAMA 331(5), 425\u2013435 (2024). https:\/\/doi.org\/10.1001\/jama.2023.26348","journal-title":"JAMA"},{"issue":"2","key":"4142_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/ijlh.12426","volume":"88","author":"N Pajam\u00e4ki","year":"2018","unstructured":"N. Pajam\u00e4ki, S. Metso, T. Hakala, T. Ebeling, H. Huhtala, E. Ry\u00f6di, J. Sand, A. Jukkola-Vuorinen, P. Kellokumpu-Lehtinen, JP, Long-term cardiovascular morbidity and mortality in patients treated for differentiated thyroid cancer. Clin. Endocrinol. 88(2), 303\u2013310 (2018). https:\/\/doi.org\/10.1111\/ijlh.12426","journal-title":"Clin. Endocrinol."},{"key":"4142_CR8","doi-asserted-by":"publisher","unstructured":"S.R. Shih, W.Y. Chiu, T.C. Chang, C.H. Tseng, Diabetes and thyroid cancer risk: literature review. J. Diabetes Res. 2012(1), 20\u201323 (2012). https:\/\/doi.org\/10.1155\/2012\/578285","DOI":"10.1155\/2012\/578285"},{"issue":"11","key":"4142_CR9","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/jbmr.4677","volume":"37","author":"JP Bilezikian","year":"2022","unstructured":"J.P. Bilezikian, A.A. Khan, S.J. Silverberg et al. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J. Bone Miner. Res. 37(11), 2293\u20132314 (2022). https:\/\/doi.org\/10.1002\/jbmr.4677","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"4142_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","volume":"14","author":"MD Walker","year":"2018","unstructured":"M.D. Walker, S.J. Silverberg, Primary hyperparathyroidism. Nat. Rev. Endocrinol. 14(2), 115\u2013125 (2018). https:\/\/doi.org\/10.1038\/nrendo.2017.104","journal-title":"Nat. Rev. Endocrinol."},{"key":"4142_CR11","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1016\/B978-0-12-801238-3.65217-0","volume":"103","author":"JP Bilezikian","year":"2018","unstructured":"J.P. Bilezikian, Primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 103, 3993\u20134004 (2018). https:\/\/doi.org\/10.1016\/B978-0-12-801238-3.65217-0","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4142_CR12","doi-asserted-by":"publisher","unstructured":"N.E. Cusano, S.J. Silverberg, J.P. Bilezikian, Normocalcemic primary hyperparathyroidism. J. Clin. Densitom. 16(1), 33\u201339 (2013). https:\/\/doi.org\/10.1016\/j.jocd.2012.12.001","DOI":"10.1016\/j.jocd.2012.12.001"},{"issue":"2","key":"4142_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.14797\/mdcj-13-2-49","volume":"13","author":"SJ Brown","year":"2017","unstructured":"S.J. Brown, M.D. Ruppe, L.S. Tabatabai, The parathyroid gland and heart disease. Methodist Debakey Cardiovasc. J 13(2), 49\u201354 (2017). https:\/\/doi.org\/10.14797\/mdcj-13-2-49","journal-title":"Methodist Debakey Cardiovasc. J"},{"issue":"8","key":"4142_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4103\/2230-8210.104042","volume":"16","author":"S Goswami","year":"2012","unstructured":"S. Goswami, S. Ghosh, Hyperparathyroidism: cancer and mortality. Indian J. Endocrinol. Metab. 16(8), 217 (2012). https:\/\/doi.org\/10.4103\/2230-8210.104042","journal-title":"Indian J. Endocrinol. Metab."},{"issue":"3","key":"4142_CR15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.amjsurg.2008.09.009","volume":"197","author":"JT Adler","year":"2009","unstructured":"J.T. Adler, R.S. Sippel, S. Schaefer, H. Chen, Surgery improves quality of life in patients with \u201cmild\u201d hyperparathyroidism. Am. J. Surg. 197(3), 284\u2013290 (2009). https:\/\/doi.org\/10.1016\/j.amjsurg.2008.09.009","journal-title":"Am. J. Surg."},{"issue":"8","key":"4142_CR16","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1210\/jc.2007-0219","volume":"92","author":"E Ambrogini","year":"2007","unstructured":"E. Ambrogini, F. Cetani, L. Cianferotti et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J. Clin. Endocrinol. Metab. 92(8), 3114\u20133121 (2007). https:\/\/doi.org\/10.1210\/jc.2007-0219","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4142_CR17","doi-asserted-by":"publisher","first-page":"456","DOI":"10.5603\/EP.2014.0063","volume":"65","author":"L Vera","year":"2014","unstructured":"L. Vera, M. Accornero, M. Dolcino, S. Oddo, M. Giusti, Five-year longitudinal evaluation of mild primary hyperparathyroidism\u2014medical treatment versus clinical observation. Endokrynol. Pol. 65(6), 456\u2013463 (2014). https:\/\/doi.org\/10.5603\/EP.2014.0063","journal-title":"Endokrynol. Pol."},{"issue":"4","key":"4142_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1530\/eje.0.1450429","volume":"145","author":"L Dell\u2019Erba","year":"2001","unstructured":"L. Dell\u2019Erba, S. Baldari, N. Borsato et al. Retrospective analysis of the association of nodular goiter with primary and secondary hyperparathyroidism. Eur. J. Endocrinol. 145(4), 429\u2013434 (2001). https:\/\/doi.org\/10.1530\/eje.0.1450429","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"4142_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00595-004-2952-9","volume":"35","author":"T Masatsugu","year":"2005","unstructured":"T. Masatsugu, H. Yamashita, S. Noguchi et al. Significant clinical differences in primary hyperparathyroidism between patients with and those without concomitant thyroid disease. Surg. Today 35(5), 351\u2013356 (2005). https:\/\/doi.org\/10.1007\/s00595-004-2952-9","journal-title":"Surg. Today"},{"key":"4142_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9461079","volume":"2018","author":"G Vargas-Ortega","year":"2018","unstructured":"G. Vargas-Ortega, L. Balc\u00e1zar-Hern\u00e1ndez, B. Gonz\u00e1lez-Virla et al. Symptomatic primary hyperparathyroidism as a risk factor for differentiated thyroid cancer. J. Thyroid Res. 2018, 1\u20136 (2018). https:\/\/doi.org\/10.1155\/2018\/9461079","journal-title":"J. Thyroid Res."},{"issue":"2","key":"4142_CR21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0030-6665(20)31292-5","volume":"23","author":"RP Walker","year":"1990","unstructured":"R.P. Walker, E. Paloyan, The relationship between Hashimoto\u2019s thyroiditis, thyroid neoplasia, and primary hyperparathyroidism. Otolaryngol. Clin. N. Am. 23(2), 291\u2013302 (1990).","journal-title":"Otolaryngol. Clin. N. Am."},{"key":"4142_CR22","doi-asserted-by":"publisher","unstructured":"S.Y. Morita, H. Somervell, C.B. Umbricht, A.P. Dackiw, M. Zeiger, Evaluation for concomitant thyroid nodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy. Surgery 144(6), 862\u2013866 (2008). https:\/\/doi.org\/10.1016\/j.surg.2008.07.029","DOI":"10.1016\/j.surg.2008.07.029"},{"issue":"4","key":"4142_CR23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.21037\/gs.2017.04.01","volume":"6","author":"MC Wright","year":"2017","unstructured":"M.C. Wright, K. Jensen, H. Mohamed et al. Concomitant thyroid disease and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy. Gland Surg. 6(4), 368\u2013374 (2017). https:\/\/doi.org\/10.21037\/gs.2017.04.01","journal-title":"Gland Surg."},{"key":"4142_CR24","doi-asserted-by":"publisher","unstructured":"B. Wagner, S. Begic-Karup, W. Raber, B. Schneider, W.V.H. Waldh\u00e4usl, Prevalence of primary hyperparathyroidism in 13387 patients with thyroid diseases, newly diagnosed by screening of serum calcium. Exp. Clin. Endocrinol. Diabetes 107(7), 457\u2013461 (1999). https:\/\/doi.org\/10.1055\/s-0029-1212138","DOI":"10.1055\/s-0029-1212138"},{"issue":"1","key":"4142_CR25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jss.2012.03.008","volume":"178","author":"S Murray","year":"2013","unstructured":"S. Murray, S. rebecca, H.C. FACS, The incidence of concomitant hyperparathyroidism in patients with thyroid disease requiring surgery. J. Surg. Res. 178(1), 264\u2013267 (2013). https:\/\/doi.org\/10.1016\/j.jss.2012.03.008","journal-title":"J. Surg. Res."},{"issue":"10","key":"4142_CR26","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1210\/jc.2014-1415","volume":"99","author":"SJ Silverberg","year":"2014","unstructured":"S.J. Silverberg, B.L. Clarke, M. Peacock et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J. Clin. Endocrinol. Metab. 99(10), 3580\u20133594 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1415","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4142_CR27","doi-asserted-by":"crossref","unstructured":"L. Castelo-Branco, A. Pellat, D. Martins-Branco, A. Valachis, J.W.G. Derksen, K.P.M. Suijkerbuijk, U. Dafni, T. Dellaporta, A. Vogel, A. Prelaj, R.H.H. Groenwold, H. Martins, R. Stahel, J. Bliss, J. Kather, N. Ribelles, F. Perrone, P.S. Hall, R. Dienstmann, C.M. Booth, G. Pentheroudakis, S. Delaloge, M. Koopman, ESMO Guidance for Reporting oncology real-World evidence (GROW). Ann. Oncol. 34(12), 1097\u20131112 (2023).","DOI":"10.1016\/j.annonc.2023.10.001"},{"key":"4142_CR28","unstructured":"F. Vescini, G. Borretta, I. Chiodini, et al. Linea guida sulla gestione terapeutica dell\u2019iperparatiroidismo primario sporadico nell\u2019adulto\u2014Istituto superiore di sanit\u00e0 2023. Published online 2023:1\u201322."},{"issue":"10","key":"4142_CR29","first-page":"295","volume":"31","author":"PL Ogburn","year":"1956","unstructured":"P.L. Ogburn, P.M. Black, Primary hyperparathyroidism and papillary adenocarcinoma of the thyroid; report of four cases. Proc. Staff Meet Mayo Clin. 31(10), 295\u2013298 (1956).","journal-title":"Proc. Staff Meet Mayo Clin."},{"issue":"3","key":"4142_CR30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.5152\/eurasianjmed.2015.119","volume":"47","author":"P Yazici","year":"2015","unstructured":"P. Yazici, M. Mihmanli, E. Bozdag, N. Aygun, M. Uludag, Incidental finding of papillary thyroid carcinoma in the patients with primary hyperparathyroidism. Eurasian J. Med. 47(3), 194\u2013198 (2015). https:\/\/doi.org\/10.5152\/eurasianjmed.2015.119","journal-title":"Eurasian J. Med."},{"key":"4142_CR31","doi-asserted-by":"publisher","unstructured":"L..A. Burmeister, M. Sandberg, S.E. Carty, C.G. Watson. Thyroid carcinoma found at parathyroidectomy: association with primary, secondary, and tertiary hyperparathyroidism. Cancer 79(8), 1611\u20131616 (1997). https:\/\/doi.org\/10.1002\/(sici)1097-0142(19970415)79:83.0.co;2-#","DOI":"10.1002\/(sici)1097-0142(19970415)79:83.0.co;2-#"},{"issue":"4","key":"4142_CR32","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3803\/ENM.2020.725","volume":"35","author":"C Jeong","year":"2021","unstructured":"C. Jeong, H.I. Kwon, H. Baek et al. Association of hyperparathyroidism and papillary thyroid cancer: a multicenter retrospective study. Endocrinol. Metab. 35(4), 925\u2013932 (2021). https:\/\/doi.org\/10.3803\/ENM.2020.725","journal-title":"Endocrinol. Metab."},{"issue":"1","key":"4142_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bj.2019.05.010","volume":"43","author":"CY Tsai","year":"2020","unstructured":"C.Y. Tsai, S.T. Chen, C. Hsueh, Y.S. Lin, J.D. Lin, Long-term therapeutic outcomes of papillary thyroid carcinoma with concomitant hyperparathyroidism: a single center case-control study. Biomed. J. 43(1), 53\u201361 (2020). https:\/\/doi.org\/10.1016\/j.bj.2019.05.010","journal-title":"Biomed. J."},{"issue":"1","key":"4142_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm13010147","volume":"13","author":"G Scerrino","year":"2024","unstructured":"G. Scerrino, N.C. Paladino, G. Orlando et al. The nexus of hyperparathyroidism and thyroid carcinoma: insights into pathogenesis and diagnostic challenges\u2014a narrative review. J. Clin. Med. 13(1), 1\u201312 (2024). https:\/\/doi.org\/10.3390\/jcm13010147","journal-title":"J. Clin. Med."},{"issue":"3","key":"4142_CR35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1054\/mehy.1999.0880","volume":"54","author":"MF McCarty","year":"2000","unstructured":"M.F. McCarty, Parathyroid hormone may be a cancer promoter\u2014an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and Vitamin D. Med. Hypotheses 54(3), 475\u2013482 (2000). https:\/\/doi.org\/10.1054\/mehy.1999.0880","journal-title":"Med. Hypotheses"},{"key":"4142_CR36","doi-asserted-by":"publisher","first-page":"418695","DOI":"10.1155\/2010\/418695","volume":"2010","author":"AS Geara","year":"2010","unstructured":"A.S. Geara, M.R. Castellanos, C. Bassil et al. Effects of parathyroid hormone on immune function. Clin. Dev. Immunol. 2010, 418695 (2010). https:\/\/doi.org\/10.1155\/2010\/418695","journal-title":"Clin. Dev. Immunol."},{"issue":"11","key":"4142_CR37","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S0344-0338(11)80895-2","volume":"190","author":"E Maiorano","year":"1994","unstructured":"E. Maiorano, A. Ambrosi, R. Giorgino, M. Fersini, L. Pollice, A. Ciampolillo, Insulin-like growth factor 1 (IGF-1) in multinodular goiters: a possible pathogenetic factor. Pathol. Res. Pract. 190(11), 1012\u20131016 (1994). https:\/\/doi.org\/10.1016\/S0344-0338(11)80895-2","journal-title":"Pathol. Res. Pract."},{"key":"4142_CR38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.mehy.2017.04.016","volume":"103","author":"M Beebeejaun","year":"2017","unstructured":"M. Beebeejaun, E. Chinnasamy, P. Wilson, A. Sharma, N. Beharry, G. Bano, Papillary carcinoma of the thyroid in patients with primary hyperparathyroidism: is there a link? Med. Hypotheses 103, 100\u2013104 (2017). https:\/\/doi.org\/10.1016\/j.mehy.2017.04.016","journal-title":"Med. Hypotheses"},{"issue":"7","key":"4142_CR39","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/00005537-199707000-00013","volume":"107","author":"RP Walker","year":"1997","unstructured":"R.P. Walker, E. Kazuko, C. Gopalsami, J. Bassali, A.M. Lawrence, E. Paloyan, Hyperparathyroidism associated with a chronic hypothyroid state. Laryngoscope 107(7), 903\u2013909 (1997). https:\/\/doi.org\/10.1097\/00005537-199707000-00013","journal-title":"Laryngoscope"},{"issue":"1","key":"4142_CR40","doi-asserted-by":"publisher","first-page":"142","DOI":"10.21037\/gs.2019.10.21","volume":"9","author":"SB Fisher","year":"2020","unstructured":"S.B. Fisher, N.D. Perrier, Primary hyperparathyroidism, and hypertension. Gland Surg. 9(1), 142\u2013149 (2020). https:\/\/doi.org\/10.21037\/gs.2019.10.21","journal-title":"Gland Surg."},{"issue":"1","key":"4142_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1677\/erc.1.01261","volume":"14","author":"IL Nilsson","year":"2007","unstructured":"I.L. Nilsson, J. Zedenius, L. Yin, A. Ekbom, The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy. Endocr. Relat. Cancer 14(1), 135\u2013140 (2007). https:\/\/doi.org\/10.1677\/erc.1.01261","journal-title":"Endocr. Relat. Cancer"},{"issue":"6","key":"4142_CR42","first-page":"435","volume":"80","author":"P Del Rio","year":"2009","unstructured":"P. Del Rio, M.F. Arcuri, L. Bezer, S. Cataldo, G. Robuschi, M. Sianesi, Association between primary hyperparathyroidism and thyroid disease. Role of preoperative PTH. Ann. Ital. Chir. 80(6), 435\u2013438 (2009).","journal-title":"Ann. Ital. Chir."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04142-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-04142-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04142-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T07:53:31Z","timestamp":1742802811000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-04142-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["4142"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-04142-2","relation":{},"ISSN":["1559-0100"],"issn-type":[{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}